Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FDMT | 4D Molecular Therapeutics, Inc. | Chief Financial & Business Officer | Dec 11, 2023 | |||
MYOV | Myovant Sciences Ltd. | Principal Financial Officer | Mar 10, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|